Skip to main contentSkip to main content
info@smcsalud.org
Dermatology

Psoriasis Treatment in Cuba

Cuba's Coriodermina — a placental-derived topical therapy — may be considered as part of a comprehensive psoriasis treatment program.

WhatsApp

Overview

Psoriasis is a chronic autoimmune skin condition that causes skin cells to multiply too quickly, resulting in thick, red, scaly patches (called plaques) on the skin. It affects about 2-3% of the world's population. While psoriasis is not contagious, it can significantly impact quality of life. There is currently no cure for psoriasis, but various treatments can help manage symptoms and reduce flare-ups. Cuba's biotechnology sector has developed Coriodermina, a topical (applied to the skin) product made from human placental extract that may be considered for the treatment of psoriasis as part of a comprehensive dermatological care program.

Symptoms

  • Red patches of skin covered with thick, silvery scales
  • Dry, cracked skin that may bleed
  • Itching, burning, or soreness
  • Thickened, pitted, or ridged nails
  • Swollen and stiff joints (psoriatic arthritis)
  • Small scaling spots (commonly in children)
  • Patches on the scalp, elbows, knees, lower back, and face

Risk Factors

  • Family history of psoriasis
  • Stress and anxiety
  • Skin injuries (cuts, scrapes, bug bites, severe sunburn)
  • Certain infections (strep throat, HIV)
  • Cold, dry weather
  • Smoking and heavy alcohol consumption
  • Certain medications (lithium, beta-blockers, antimalarials)
  • Obesity
  • Rapid withdrawal of oral or systemic corticosteroids

Diagnosis

Diagnosis is primarily based on physical examination of the skin, nails, and scalp. A dermatologist can usually diagnose psoriasis by its characteristic appearance. In some cases, a skin biopsy may be performed to confirm the diagnosis and rule out other skin conditions. Cuban dermatology centers provide comprehensive dermatological evaluation.

Disease Stages

Psoriasis is classified by severity based on the percentage of body surface area affected and the impact on quality of life. Mild: Less than 3% of body surface area affected. Moderate: 3-10% of body surface area affected. Severe: More than 10% of body surface area affected. Psoriasis is also classified by type: plaque psoriasis (most common), guttate, inverse, pustular, and erythrodermic. Treatment approaches vary by type and severity.

Standard Treatment Options

topical

Topical treatments are the first line of treatment for mild to moderate psoriasis. These include corticosteroids, vitamin D analogues (calcipotriene), retinoids, coal tar, and moisturizers. Cuba's Coriodermina is a placental-derived topical product that may be considered as part of a comprehensive topical treatment regimen.

phototherapy

Phototherapy (light therapy) uses ultraviolet light to slow skin cell proliferation. Types include narrowband UVB, broadband UVB, and psoralen plus UVA (PUVA). Phototherapy may be used for moderate to severe psoriasis that does not respond to topical treatments.

systemic

Systemic medications are used for moderate to severe psoriasis. These include oral medications (methotrexate, cyclosporine, acitretin) and biologic medications (adalimumab, etanercept, ustekinumab). Systemic treatment requires monitoring for side effects.

biotechnology

Cuba's Coriodermina is a placental-derived topical product developed by Cuba's biotechnology sector. It contains growth factors and other bioactive compounds that may help regulate skin cell proliferation and reduce inflammation. Coriodermina may be considered as part of a comprehensive psoriasis treatment program.

supportive

Supportive care includes moisturizers to reduce dryness and itching, stress management techniques, avoidance of triggers, dietary modifications, and psychological support. Patient education on skin care and trigger avoidance is an important component of management.

lifestyle

Lifestyle modifications include maintaining a healthy weight, avoiding smoking and excessive alcohol, managing stress, protecting skin from injury, using gentle skin care products, and avoiding known triggers. These measures can help reduce flare-ups and improve treatment outcomes.

Potential Treatment Approaches in Cuba

Cuba's approach to psoriasis includes the use of Coriodermina, a placental-derived topical product developed by Cuba's biotechnology sector. Coriodermina contains growth factors and other bioactive compounds that may help regulate skin cell proliferation and reduce inflammation. It may be considered as part of a comprehensive dermatological treatment program that also includes topical treatments, phototherapy, and supportive care. For international patients, the process begins with a thorough review of medical records to determine if Coriodermina therapy may be appropriate for their specific case.

Cuban Treatment Options

Explore Cuba's Treatment for This Condition

Cuba offers specialized treatment programs for this condition. Learn more about the therapy, eligibility, and how to request a medical evaluation.

Who May Be Eligible

Eligibility for Coriodermina therapy is determined through medical review of the patient's psoriasis type, severity, previous treatments, and overall health. Coriodermina may be considered for patients with mild to moderate plaque psoriasis. Each case is evaluated individually by the Cuban dermatology team. Patients must provide complete medical records including psoriasis history and previous treatments for review.

Required Medical Documents

  • Dermatologist's diagnosis and clinical history
  • Description of psoriasis type, severity, and affected areas
  • Previous treatment history (topical, phototherapy, systemic, biologic)
  • Current medication list
  • Recent general blood panel
  • Photographs of affected areas if available
  • Allergy history

How to Request a Medical Evaluation

Submit your medical records for review by our oncology team. If treatment may be appropriate for your case, a personalized plan will be developed. You only travel to Cuba after the medical team confirms eligibility.

Call WhatsApp

Frequently Asked Questions

What is Coriodermina and how does it work?

Coriodermina is a placental-derived topical product developed by Cuba's biotechnology sector. It contains growth factors and other bioactive compounds that may help regulate skin cell proliferation and reduce inflammation. It may be considered as part of a comprehensive psoriasis treatment program.

Can international patients receive psoriasis treatment in Cuba?

Yes. International patients may be evaluated for psoriasis treatment through SMC Salud. The process begins with a medical review of your records. If the dermatology team determines that treatment may be appropriate, a personalized plan is developed.

Can psoriasis be cured in Cuba?

No treatment can guarantee a cure for psoriasis. It is a chronic condition that requires ongoing management. Cuba's Coriodermina and other treatments may help manage symptoms, reduce flare-ups, and improve quality of life. Outcomes vary by individual and depend on the type and severity of psoriasis.

How long does psoriasis treatment in Cuba take?

The treatment duration varies by individual case. Topical treatments like Coriodermina are typically applied over several weeks or months. Your medical team will provide a personalized timeline after reviewing your records.

Can my medical records be reviewed before I travel?

Yes. Medical record review is a required first step. You submit your documents remotely, and the dermatology team reviews them to determine whether treatment may be appropriate. You only travel to Cuba if the team confirms that evaluation or treatment may be offered.

References

  • World Health Organization — Psoriasis Fact Sheet.
  • American Academy of Dermatology — Psoriasis Treatment Guidelines.
  • International Psoriasis Council — Treatment Recommendations.

Medical Disclaimer

The medical information provided on this page is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Eligibility for any treatment depends on the patient's clinical condition and is determined by the treating medical team.

This content has been medically reviewed by qualified physicians and follows SMC Salud's editorial policy for health information. Medical content is for informational purposes and does not replace professional medical advice.

Related Information